| Financial Year |
March 31 2023 |
| Monetary Funds |
210,895,485.64 |
| Held-for-trading Financial Assets |
43,247,684.85 |
| Notes Receivable |
16,287,025.55 |
| Accounts Receivable |
544,199,671.81 |
| Advances to Suppliers |
3,353,505.70 |
| Other Receivables |
22,997,396.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
348,139,520.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,672,974.55 |
| Total Current Assets |
1,475,821,120.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
871,860,663.61 |
| Under-construction Projects |
276,690,817.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,162,061.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,646,252.05 |
| Deferred Income Tax Assets |
26,163,651.40 |
| Other Non-Current Assets |
2,347,029.13 |
| Sub-Total of Non-Current Assets |
1,308,764,772.69 |
| Total Assets |
2,784,585,893.56 |
| Short-Term Loans |
119,697,712.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
297,761,694.19 |
| Accounts Payable |
384,054,028.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,832,249.71 |
| Taxes Payable |
12,599,674.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,912,808.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,231,707.68 |
| Other Current Liabilities |
675,132.99 |
| Sub-Total of Current Liabilities |
879,488,802.24 |
| Long-term Loans |
139,104,232.20 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,462,706.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
166,911,166.02 |
| Total Liabilities |
1,046,399,968.26 |
| Paid-In Capital(Or Share Stock) |
175,881,318.00 |
| Capital Surplus |
979,045,309.96 |
| Surplus Reserve |
26,839,061.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
516,834,977.30 |
| Minority Stockholder's Interest |
41,578,846.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,696,607,078.62 |
| Owner's Equity（Stockholder's Equity） |
1,738,185,925.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,784,585,893.56 |
